AI & ChatGPT searches , social queries for CGMP

Search references for CGMP. Phrases containing CGMP

See searches and references containing CGMP!

AI searches containing CGMP

CGMP

  • CGMP
  • Topics referred to by the same term

    CGMP is an initialism. It can refer to: cyclic guanosine monophosphate (cGMP) current good manufacturing practice (cGMP) CGMP, Cisco Group Management

    CGMP

    CGMP

  • Good manufacturing practice
  • Manufacturing quality standards

    Current good manufacturing practices (cGMP) are those conforming to the guidelines recommended by relevant agencies. Those agencies control the authorization

    Good manufacturing practice

    Good_manufacturing_practice

  • Sildenafil
  • Drug for erectile dysfunction and hypertension

    blocking phosphodiesterase 5 (PDE5), an enzyme that promotes breakdown of cGMP, which regulates blood flow in the penis. It requires sexual arousal to work

    Sildenafil

    Sildenafil

    Sildenafil

  • Cyclic guanosine monophosphate
  • Chemical compound

    Cyclic guanosine monophosphate (cGMP) is a cyclic nucleotide derived from guanosine triphosphate (GTP). cGMP acts as a second messenger much like cyclic

    Cyclic guanosine monophosphate

    Cyclic guanosine monophosphate

    Cyclic_guanosine_monophosphate

  • CGMP-specific phosphodiesterase type 5
  • Mammalian protein found in humans

    belong to a large family of cyclic nucleotide PDEs that catalyze cAMP and cGMP hydrolysis. The interest in PDEs as molecular targets of drug action has

    CGMP-specific phosphodiesterase type 5

    CGMP-specific phosphodiesterase type 5

    CGMP-specific_phosphodiesterase_type_5

  • CGMP-dependent protein kinase
  • Protein kinase

    cGMP-dependent protein kinase or protein kinase G (PKG) is a serine/threonine-specific protein kinase that is activated by cGMP. It phosphorylates a number

    CGMP-dependent protein kinase

    CGMP-dependent protein kinase

    CGMP-dependent_protein_kinase

  • Cyclic nucleotide–gated ion channel
  • Family of transport proteins

    can be the result of a combination of the binding of cyclic nucleotides (cGMP and cAMP) and either a depolarization or a hyperpolarization event. Initially

    Cyclic nucleotide–gated ion channel

    Cyclic nucleotide–gated ion channel

    Cyclic_nucleotide–gated_ion_channel

  • Phenylketonuria
  • Amino acid metabolic disorder

    is casein glycomacropeptide (CGMP), which is a milk peptide naturally free of Phe in its pure form.[citation needed] CGMP can substitute for the main part

    Phenylketonuria

    Phenylketonuria

    Phenylketonuria

  • Visual phototransduction
  • Process by which light activates retinal cells

    within the cGMP-gated cation channels more sensitive to low cGMP levels (thereby, keeping the cGMP-gated cation channel open even at low cGMP levels, restoring

    Visual phototransduction

    Visual_phototransduction

  • Guanylate cyclase
  • Lyase enzyme that synthesizes cGMP from GTP

    cyclase synthesizes cGMP from GTP. cGMP keeps cGMP-gated channels open, allowing for the entry of calcium into the cell. Like cAMP, cGMP is an important second

    Guanylate cyclase

    Guanylate cyclase

    Guanylate_cyclase

  • Achromatopsia
  • Medical condition

    CNGB3 function or gain of function—often increased affinity for cGMP—of CNGA3. cGMP levels are controlled by the activity of the cone cell transducin

    Achromatopsia

    Achromatopsia

  • Discovery and development of phosphodiesterase 5 inhibitors
  • Drug discovery

    platelets. It is possible to prevent cGMP hydrolysis by inhibiting PDE5 and therefore treat diseases associated with low cGMP levels; because of this, PDE5 is

    Discovery and development of phosphodiesterase 5 inhibitors

    Discovery_and_development_of_phosphodiesterase_5_inhibitors

  • Phosphodiesterase
  • Class of enzymes

    degrade the phosphodiester bond in the second messenger molecules cAMP and cGMP. They regulate the localization, duration, and amplitude of cyclic nucleotide

    Phosphodiesterase

    Phosphodiesterase

    Phosphodiesterase

  • List of phosphodiesterase inhibitors
  • The following is a list of phosphodiesterase inhibitors. Adibendan Aminophylline Aminophylline dihydrate Amipizone Apremilast Arofylline Atizoram Befuraline

    List of phosphodiesterase inhibitors

    List_of_phosphodiesterase_inhibitors

  • Tadalafil
  • Medication used to treat erectile dysfunction

    monophosphate (more commonly known as cyclic GMP or cGMP) in smooth muscle cells.[medical citation needed] cGMP relaxes smooth muscle and increases blood flow

    Tadalafil

    Tadalafil

    Tadalafil

  • Rod cell
  • Photoreceptor cells that can function in lower light better than cone cells

    the activation of cGMP phosphodiesterase, which hydrolyzes cGMP (the second messenger), breaking it down into 5'-GMP. Reduction in cGMP allows the ion channels

    Rod cell

    Rod cell

    Rod_cell

  • Guanosine monophosphate
  • Chemical compound

    cyclic GMP. Within certain cells the enzyme guanylyl cyclase makes cGMP from GTP. cGMP plays an important role in mediating hormonal signaling. GMP was

    Guanosine monophosphate

    Guanosine monophosphate

    Guanosine_monophosphate

  • PDE11A
  • Protein-coding gene in the species Homo sapiens

    humans is encoded by the PDE11A gene. The 3',5'-cyclic nucleotides cAMP and cGMP function as second messengers in a wide variety of signal transduction pathways

    PDE11A

    PDE11A

    PDE11A

  • Atrial natriuretic peptide
  • Cardiac hormone which increases renal sodium excretion

    receptor causes the conversion of GTP to cGMP and raises intracellular cGMP. As a consequence, cGMP activates a cGMP-dependent kinase (PKG or cGK) that phosphorylates

    Atrial natriuretic peptide

    Atrial natriuretic peptide

    Atrial_natriuretic_peptide

  • Cell signaling
  • System of communication

    cGMP Regulation of Kinases and channels- Diverse actions Cytoplasmic Guanylyl cyclase Nitric Oxide (Nitric oxide receptor) cGMP Regulation of cGMP Gated

    Cell signaling

    Cell signaling

    Cell_signaling

  • PDE5 inhibitor
  • Vasodilating drug

    is a vasodilating drug that works by blocking the degradative action of cGMP-specific phosphodiesterase type 5 (PDE5) on cyclic GMP in the smooth muscle

    PDE5 inhibitor

    PDE5 inhibitor

    PDE5_inhibitor

  • PDE10A
  • Enzyme and protein-coding gene in humans

    cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A is an enzyme that in humans is encoded by the PDE10A gene. Various cellular responses are

    PDE10A

    PDE10A

    PDE10A

  • Resumption of meiosis
  • rapid decrease in cGMP levels in the granulosa cells and the oocytes through the gap junctions. PDE5 is also activated, increasing cGMP hydrolysis. In mouse

    Resumption of meiosis

    Resumption_of_meiosis

  • Phosphodiester bond
  • –O– linkage between phosphoric acid and two other compounds

    acyl carrier proteins, phospholipids and the cyclic forms of GMP and AMP (cGMP and cAMP). Phosphodiester bonds make up the backbones of DNA and RNA. In

    Phosphodiester bond

    Phosphodiester bond

    Phosphodiester_bond

  • GAF domain
  • Protein domain

    species. The GAF domain is named after some of the proteins it is found in: cGMP-specific phosphodiesterases, adenylyl cyclases and FhlA. The first structure

    GAF domain

    GAF domain

    GAF_domain

  • Transducin
  • Heterotrimeric G protein involved in vertebrate phototransduction

    α-subunit activates cGMP phosphodiesterase. cGMP phosphodiesterase breaks down cGMP, an intracellular second messenger which opens cGMP-gated cation channels

    Transducin

    Transducin

    Transducin

  • Photoreceptor cell
  • Type of neuroepithelial cell

    transducin then activates the enzyme cGMP-specific phosphodiesterase (PDE). PDE then catalyzes the hydrolysis of cGMP to 5' GMP. This is the second amplification

    Photoreceptor cell

    Photoreceptor cell

    Photoreceptor_cell

  • Clitoral erection
  • Physiological phenomenon involving the engorgement of the clitoris

    (2004). The neurovascular mechanism of clitoral erection: Nitric oxide and cGMP‐stimulated activation of BKCa channels. The FASEB journal, 18(12), 1382-1391

    Clitoral erection

    Clitoral erection

    Clitoral_erection

  • Nitric oxide
  • Colorless gas with the formula NO

    oxide pathway by protecting cyclic guanosine monophosphate (cGMP) from degradation by cGMP-specific phosphodiesterase type 5 (PDE5) in the corpus cavernosum

    Nitric oxide

    Nitric oxide

    Nitric_oxide

  • Dietary supplement
  • Product providing additional nutrients

    Good Manufacturing Practices (CGMP) and labeling with science-based ingredient descriptions and advertising. When finding CGMP or advertising violations,

    Dietary supplement

    Dietary supplement

    Dietary_supplement

  • FDA warning letter
  • US government message type

    the award of federal contracts. If current good manufacturing practice (cGMP) violations are cited, it adds a statement regarding the potential impact

    FDA warning letter

    FDA_warning_letter

  • Ranbaxy Laboratories
  • Defunct Indian pharmaceutical manufacturer

    Toansa facility, which concluded on 11 January 2014, identified significant cGMP violations. These included Toansa staff retesting raw materials, intermediate

    Ranbaxy Laboratories

    Ranbaxy_Laboratories

  • PDE6A
  • Protein-coding gene in the species Homo sapiens

    Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha is an enzyme that in humans is encoded by the PDE6A gene. PDE6A encodes the cyclic-GMP (cGMP)

    PDE6A

    PDE6A

    PDE6A

  • Phosphodiesterase inhibitor
  • Drug

    cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) by the respective PDE subtype(s). The ubiquitous presence of this enzyme

    Phosphodiesterase inhibitor

    Phosphodiesterase inhibitor

    Phosphodiesterase_inhibitor

  • Pulmonary hypertension
  • Increased blood pressure in lung arteries

    formation of cyclic guanosine monophosphate (cGMP) from guanosine triphosphate (GTP). The cGMP then activates cGMP-dependent kinase or PKG (protein kinase

    Pulmonary hypertension

    Pulmonary hypertension

    Pulmonary_hypertension

  • Nitroglycerin (medication)
  • Medication

    guanosine monophosphate (cGMP) from guanosine triphosphate (GTP). Among other roles, cGMP serves as a substrate for a cGMP-dependent protein kinase that

    Nitroglycerin (medication)

    Nitroglycerin (medication)

    Nitroglycerin_(medication)

  • SCTbio
  • Medicinal therapy product manufacturer

    services (CDMO) for Advanced Therapy Medicinal Products (ATMPs), utilizing cGMP standards. Operating in Europe and North America, the company specializes

    SCTbio

    SCTbio

    SCTbio

  • Form FDA 483
  • Documents observations in inspections

    Dispute Resolution: Scientific and Technical Issues Related to Pharmaceutical CGMP, and they have 30 calendar days to do so. The FDA refers to cellular and

    Form FDA 483

    Form_FDA_483

  • Adaptation (eye)
  • Response of the eye to light and dark

    Under scotopic conditions, intracellular cGMP concentration is high in photoreceptors. cGMP binds to and opens cGMP gated Na+ channels to allow sodium and

    Adaptation (eye)

    Adaptation_(eye)

  • Adderall
  • Drug mixture used mainly to treat ADHD and narcolepsy

    for marketing purposes. The FDA cited the company for numerous significant CGMP violations related to Obetrol discovered during routine inspections following

    Adderall

    Adderall

    Adderall

  • Helicine arteries of penis
  • Arteries of the penis

    monophosphate (cGMP). cGMP in turn triggers relaxation of the smooth muscle and results in dilation of blood vessels. This signal is terminated when cGMP is broken

    Helicine arteries of penis

    Helicine arteries of penis

    Helicine_arteries_of_penis

  • Guanosine
  • Chemical compound

    to become guanosine monophosphate (GMP), cyclic guanosine monophosphate (cGMP), guanosine diphosphate (GDP), and guanosine triphosphate (GTP). These forms

    Guanosine

    Guanosine

    Guanosine

  • Pulmonary arterial hypertension
  • High blood pressure in the pulmonary arteries

    vessels by inhibiting the degradation of Cyclic guanosine monophosphate (cGMP). cGMP inhibits pulmonary artery smooth muscle proliferation and causes pulmonary

    Pulmonary arterial hypertension

    Pulmonary arterial hypertension

    Pulmonary_arterial_hypertension

  • Parietal eye
  • Part of the epithalamus

    Xiong, Wei-Hong; Solessio, Eduardo C.; Yau, King-Wai (1998). "An unusual cGMP pathway underlying depolarizing light response of the vertebrate parietal-eye

    Parietal eye

    Parietal eye

    Parietal_eye

  • Ipratropium bromide
  • Anticholinergic used in the treatment of asthma

    guanosine monophosphate (cGMP), resulting in a decreased intracellular concentration of cGMP. Most likely due to actions of cGMP on intracellular calcium

    Ipratropium bromide

    Ipratropium bromide

    Ipratropium_bromide

  • Nitrovasodilator
  • Drug that causes vasodilation by releasing nitric oxide

    Guanylate cyclase produces cyclic guanosine monophosphate (cGMP) from guanosine triphosphate (GTP). cGMP in turn activates cyclic nucleotide-dependent protein

    Nitrovasodilator

    Nitrovasodilator

    Nitrovasodilator

  • Sodium nitroprusside
  • Medication for lowering blood pressure

    It works by increasing nitric oxide levels in the blood, which increases cGMP levels in cells, and causes dilation of blood vessels. Sodium nitroprusside

    Sodium nitroprusside

    Sodium nitroprusside

    Sodium_nitroprusside

  • Brain natriuretic peptide 32
  • Hormone secreted in the heart

    collecting duct of the nephron via guanosine 3',5'-cyclic monophosphate (cGMP) dependent phosphorylation of ENaC. BNP and NT-proBNP are measured by immunoassay

    Brain natriuretic peptide 32

    Brain natriuretic peptide 32

    Brain_natriuretic_peptide_32

  • PDE1
  • Enzyme

    isoforms. The various isoforms exhibit different affinities for cAMP and cGMP. The existence of the Ca2+-stimulated Phosphodiesterase 1 was first demonstrated

    PDE1

    PDE1

  • Linaclotide
  • Medicine

    doses. Activation of GC-C increases cyclic guanosine monophosphate (cGMP). Elevated cGMP stimulates secretion of chloride and bicarbonate and water into the

    Linaclotide

    Linaclotide

    Linaclotide

  • Meiosis
  • Cell division producing haploid gametes

    cyclic guanosine 3′,5′-monophosphate (cGMP) in concert with natriuretic peptide receptor 2 (NPR2) on cumulus cells. cGMP diffuses into oocytes and halts meiosis

    Meiosis

    Meiosis

    Meiosis

  • Hydrogen sulfide
  • Poisonous and flammable gas

    resulting in several different cellular effects, including the inhibition of cGMP phosphodiesterases, as well as the formation of nitroxyl and thionitrous

    Hydrogen sulfide

    Hydrogen sulfide

    Hydrogen_sulfide

  • Hyaluronic acid
  • Physiological molecule and therapeutic drug

    "Hyaluronan export by the ABC transporter MRP5 and its modulation by intracellular cGMP". J. Biol. Chem. 282 (29): 20999–21004. doi:10.1074/jbc.M700915200. PMID 17540771

    Hyaluronic acid

    Hyaluronic acid

    Hyaluronic_acid

  • Amhara people
  • Semitic-speaking ethnic group in Ethiopia

    but not Oromo, had higher NO3- and cGMP compared with their lowland counterparts. NO3- directly correlated with cGMP." There are four major world regions

    Amhara people

    Amhara people

    Amhara_people

  • Biological functions of nitric oxide
  • Functions of nitric oxide in organisms

    cyclic-guanosine 3',5'-monophosphate (cGMP). The elevation of intracellular cGMP results in relaxation by the activation of cGMP-dependent protein kinase, which

    Biological functions of nitric oxide

    Biological_functions_of_nitric_oxide

  • Red blood cell
  • Oxygen-delivering blood cell and the most common type of blood cell

    xenobiotics. Excessive eryptosis is observed in red blood cells lacking the cGMP-dependent protein kinase type I or the AMP-activated protein kinase AMPK

    Red blood cell

    Red blood cell

    Red_blood_cell

  • Julphar
  • Pharmaceutical company based in the United Arab Emirates

    facility was the first in King Abdullah Economic City to be awarded full cGMP certification on its first inspection by the Saudi Food and Drug Authority

    Julphar

    Julphar

    Julphar

  • Nucleotide
  • Biological molecules constituting nucleic acids

    nucleotides participate in cell signaling (cyclic guanosine monophosphate or cGMP and cyclic adenosine monophosphate or cAMP) and are incorporated into important

    Nucleotide

    Nucleotide

    Nucleotide

  • Duloxetine
  • SNRI medication

    approvable from the manufacturing and control standpoint" because of "significant cGMP (current Good Manufacturing Practice) violations at the finished product

    Duloxetine

    Duloxetine

    Duloxetine

  • Nitrate
  • Polyatomic ion (NO3, charge –1) found in explosives and fertilisers

    non-selective PDE inhibitors (e.g., caffeine) PDE9 inhibitors (e.g., paraxanthine) cGMP preferring PDE inhibitors (e.g., sildenafil, paraxanthine, tadalafil) Statins

    Nitrate

    Nitrate

    Nitrate

  • Butterfly valve
  • Flow control device

    The valves used in these industries are usually manufactured according to cGMP guidelines (current good manufacturing practice). Butterfly valves generally

    Butterfly valve

    Butterfly valve

    Butterfly_valve

  • List of medical abbreviations: C
  • impression (including subscales such as CGI-BP, CGI-C, CGI-E, CGI-I, CGI-S) cGMP cyclic guanosine monophosphate CGN chronic glomerulonephritis CH congenital

    List of medical abbreviations: C

    List_of_medical_abbreviations:_C

  • Therapure BioPharma Inc
  • Canadian biopharmaceutical industry and biotechnology company

    & process development, analytical development and testing, scale up and cGMP manufacturing, and aseptic fill/finish and lyophilization. As of 2010[update]

    Therapure BioPharma Inc

    Therapure BioPharma Inc

    Therapure_BioPharma_Inc

  • Pulmonary edema
  • Fluid accumulation in the tissue and air spaces of the lungs

    Sildenafil's mechanism of action is via phosphodiesterase inhibition which raises cGMP, resulting in pulmonary arterial vasodilation and inhibition of smooth muscle

    Pulmonary edema

    Pulmonary edema

    Pulmonary_edema

  • Spermidine
  • Chemical compound

    receptor), which has been associated with nitric oxide synthase (NOS) and cGMP/PKG pathway activation and a decrease of Na+,K+-ATPase activity in cerebral

    Spermidine

    Spermidine

    Spermidine

  • Smooth muscle
  • Involuntary non-striated muscle

    membrane bound adenylate cyclase, respectively. The cyclic nucleotides (cGMP and cAMP) produced by these cyclases activate Protein Kinase G and Protein

    Smooth muscle

    Smooth muscle

    Smooth_muscle

  • List of human hormones
  • Atrial natriuretic peptide (or atriopeptin) ANP Peptide heart ANP receptor → cGMP increase sodium and GFR excretion, antagonize venal constriction, inhibit

    List of human hormones

    List_of_human_hormones

  • Rhodopsin
  • Light-sensitive receptor protein

    cGMP phosphodiesterase. The cGMP phosphodiesterase hydrolyzes (breaks down) cGMP, lowering its local concentration so it can no longer activate cGMP-dependent

    Rhodopsin

    Rhodopsin

    Rhodopsin

  • Nitric oxide synthase
  • Class of enzymes

    cyclase, which induces smooth muscle relaxation by: Increased intracellular cGMP, which inhibits calcium entry into the cell, and decreases intracellular

    Nitric oxide synthase

    Nitric oxide synthase

    Nitric_oxide_synthase

  • Phosphodiesterase 2
  • Class of enzymes

    (PDE 4, -7 and -8), others are cGMP selective hydrolases (PDE 5, -6 and -9) and the rest can hydrolyse both cAMP and cGMP (PDE1, -2, -3, -10 and -11). There

    Phosphodiesterase 2

    Phosphodiesterase 2

    Phosphodiesterase_2

  • Death during consensual sex
  • Circumstance of death

    patients with erectile dysfunction. One treatment for erectile dysfunction is cGMP-specific phosphodiesterase type 5 inhibitors, which enable patients to resume

    Death during consensual sex

    Death_during_consensual_sex

  • Second messenger system
  • System of signaling molecules within a cell

    proteins. Hydrophilic molecules: water-soluble molecules, such as cAMP, cGMP, IP3, and Ca2+, that are located within the cytosol. Gases: nitric oxide

    Second messenger system

    Second messenger system

    Second_messenger_system

  • Commonly prescribed drugs
  • Type of drugs

    in body → release nitric oxide → increase cyclic guanosine monophosphate (cGMP) → vasodilating effects predominant on veins and epicardial coronary vessels

    Commonly prescribed drugs

    Commonly_prescribed_drugs

  • 8-Bromoguanosine 3',5'-cyclic monophosphate
  • Chemical compound

    brominated derivative of cyclic guanosine monophosphate (cGMP). It acts as an activator of cGMP-dependent protein kinases. 8-Bromoadenosine 3′,5′-cyclic

    8-Bromoguanosine 3',5'-cyclic monophosphate

    8-Bromoguanosine 3',5'-cyclic monophosphate

    8-Bromoguanosine_3',5'-cyclic_monophosphate

  • Phosphodiesterase 3
  • Class of enzymes

    by PDE3 isoforms is also directly inhibited by cGMP, although PDE3B is only ≈10% as sensitive to cGMP inhibition as PDE3A. The PDE3B has been extensively

    Phosphodiesterase 3

    Phosphodiesterase 3

    Phosphodiesterase_3

  • Amyl nitrite
  • Chemical compound

    non-selective PDE inhibitors (e.g., caffeine) PDE9 inhibitors (e.g., paraxanthine) cGMP preferring PDE inhibitors (e.g., sildenafil, paraxanthine, tadalafil) Statins

    Amyl nitrite

    Amyl nitrite

    Amyl_nitrite

  • Patheon
  • Pharmaceutical company

    the Patheon brand include small molecule API, biologics, viral vectors, cGMP plasmids, formulation, clinical trials, logistics and commercial manufacturing

    Patheon

    Patheon

  • PDE6C
  • Protein-coding gene in the species Homo sapiens

    Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha' is an enzyme that in humans is encoded by the PDE6C gene. GRCh38: Ensembl release 89:

    PDE6C

    PDE6C

    PDE6C

  • David Kass (physician)
  • American Physician-Scientist

    phosphodiesterase type 5A(PDE5A), which degraded Cyclic guanosine monophosphate(cGMP) and was inhibited by the drug sildenafil (Viagra®), blunted heart contractility

    David Kass (physician)

    David Kass (physician)

    David_Kass_(physician)

  • Guanylate cyclase-coupled receptor
  • Protein family

    receptor is activated by the ligation, it can cyclize the guanylate into cGMP. An example of Guanylate cyclase-coupled receptors is ANF receptors (NPR1

    Guanylate cyclase-coupled receptor

    Guanylate_cyclase-coupled_receptor

  • Transduction (psychology)
  • monophosphate (cGMP) plays an important role in visual transductions. This fact was well rooted when Fesenko demonstrated that this nucleotide cGMP was able

    Transduction (psychology)

    Transduction_(psychology)

  • MRVI1
  • Protein-coding gene in the species Homo sapiens

    between the inositol 1,4,5-trisphosphate receptor-associated cGMP kinase substrate (IRAG) and cGMP kinase Ibeta". J. Biol. Chem. 276 (26): 24153–9. doi:10

    MRVI1

    MRVI1

    MRVI1

  • Wharton's jelly
  • Gelatinous substance within the umbilical cord

    The email stated that the products are "manufactured in an FDA-registered, cGMP compliant, ISO certified lab", but did not mention that such birth products

    Wharton's jelly

    Wharton's jelly

    Wharton's_jelly

  • C-Jun N-terminal kinases
  • Chemical compounds

    protein kinase (EC 2.7.11.11) Protein kinase A PRKACG PRKACB PRKACA PRKY cGMP-dependent protein kinase (EC 2.7.11.12) Protein kinase G PRKG1 Protein kinase

    C-Jun N-terminal kinases

    C-Jun N-terminal kinases

    C-Jun_N-terminal_kinases

  • Corrective and preventive action
  • Improvements in an organization to eliminate non-conformities or undesirable situations

    gov. 16 May 2022. Archived from the original on May 13, 2022. Retrieved 2023-03-09. Quality Systems Approach to Pharmaceutical CGMP Regulations (FDA)

    Corrective and preventive action

    Corrective_and_preventive_action

  • Neurotoxin
  • Toxin harmful to nervous tissue

    induce swelling of astrocytes in the brain through increased production of cGMP (Cyclic Guanosine Monophosphate) within the cells which leads to Protein

    Neurotoxin

    Neurotoxin

    Neurotoxin

  • Cyclic nucleotide phosphodiesterase
  • Class of enzymes

    catalyze the hydrolysis of cAMP or cGMP to their 5′ monophosphate form. Both enzymes also bind cGMP with high affinity. The cGMP-binding sites are located in

    Cyclic nucleotide phosphodiesterase

    Cyclic nucleotide phosphodiesterase

    Cyclic_nucleotide_phosphodiesterase

  • Trequinsin
  • Chemical compound

    in vitro. Whitaker, RM; Wills, LP; Stallons, LJ; Schnellmann, RG (2013). "CGMP-Selective Phosphodiesterase Inhibitors Stimulate Mitochondrial Biogenesis

    Trequinsin

    Trequinsin

    Trequinsin

  • Mitogen-activated protein kinase
  • P38 mitogen-activated protein kinases

    protein kinase (EC 2.7.11.11) Protein kinase A PRKACG PRKACB PRKACA PRKY cGMP-dependent protein kinase (EC 2.7.11.12) Protein kinase G PRKG1 Protein kinase

    Mitogen-activated protein kinase

    Mitogen-activated_protein_kinase

  • Cyclic nucleotide
  • Cyclic nucleic acid

    cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) images, the 'cyclic' portion consists of two bonds between the phosphate

    Cyclic nucleotide

    Cyclic nucleotide

    Cyclic_nucleotide

  • Ulrich Walter (clinical biochemist)
  • German physician and biomedical scientist

    (AKAPs), which define cellular PKA responses. Efforts to elucidate cAMP/cGMP mechanisms in cardiovascular cells were then directed to identify selective

    Ulrich Walter (clinical biochemist)

    Ulrich_Walter_(clinical_biochemist)

  • Mosliciguat
  • Chemical compound

    Achim (August 2023). "The 10th International Conference on cGMP 2022: recent trends in cGMP research and development—meeting report". Naunyn-Schmiedeberg's

    Mosliciguat

    Mosliciguat

    Mosliciguat

  • Natriuretic peptide
  • Hormone used in regulating the cardiovascular system

    Receptor-C (NPR-C). NPR-A and NPR-B use cyclic guanosine monophosphate (cGMP) as its intracellular messenger. NPR-A binds selectively to ANP and BNP while

    Natriuretic peptide

    Natriuretic peptide

    Natriuretic_peptide

  • Herbal medicine
  • Study and use of medicinal properties of plants

    and Drug Administration (FDA) under current good manufacturing practice (cGMP) policy for dietary supplements. Manufacturers of products falling into this

    Herbal medicine

    Herbal medicine

    Herbal_medicine

  • Receptor (biochemistry)
  • Protein molecule receiving signals for a cell

    Receptor Ligand Ion current cyclic nucleotide-gated ion channels cGMP (vision), cAMP and cGTP (olfaction) Na+, K+ IP3 receptor IP3 Ca2+ Intracellular ATP

    Receptor (biochemistry)

    Receptor (biochemistry)

    Receptor_(biochemistry)

  • Paraxanthine
  • Chemical compound

    but weaker than theophylline. Paraxanthine is a selective inhibitor of cGMP-preferring phosphodiesterase (PDE9) activity and is hypothesized to increase

    Paraxanthine

    Paraxanthine

    Paraxanthine

  • List of enzymes
  • bisphosphatase (EC 3.1.3.11) Category:EC 3.1.4 Phospholipase C (EC 3.1.4.3) CGMP specific phosphodiesterase type 5 (EC 3.1.4.17) Phospholipase D (EC 3.1.4

    List of enzymes

    List_of_enzymes

  • Dipyridamole
  • Anticoagulant drug

    cAMP levels and blocking the platelet aggregation, response to ADP) and/or cGMP. Dipyridamole inhibits the cellular reuptake of adenosine into platelets

    Dipyridamole

    Dipyridamole

    Dipyridamole

  • Cyclin-dependent kinase
  • Class of enzymes

    protein kinase (EC 2.7.11.11) Protein kinase A PRKACG PRKACB PRKACA PRKY cGMP-dependent protein kinase (EC 2.7.11.12) Protein kinase G PRKG1 Protein kinase

    Cyclin-dependent kinase

    Cyclin-dependent kinase

    Cyclin-dependent_kinase

  • Avanafil
  • Chemical compound

    inhibits phosphodiesterase-5, preventing the degradation of cGMP. The increased levels of cGMP causes vasodilation, resulting in an increased blood flow

    Avanafil

    Avanafil

    Avanafil

AI & ChatGPT searchs for online references containing CGMP

CGMP

AI search references containing CGMP

CGMP

AI search queries for Facebook and twitter posts, hashtags with CGMP

CGMP

Follow users with usernames @CGMP or posting hashtags containing #CGMP

CGMP

Online names & meanings

AI search & ChatGPT queries for Facebook and twitter users, user names, hashtags with CGMP

CGMP

Top AI & ChatGPT search, Social media, medium, facebook & news articles containing CGMP

CGMP

AI searchs for Acronyms & meanings containing CGMP

CGMP

AI searches, Indeed job searches and job offers containing CGMP

Other words and meanings similar to

CGMP

AI search in online dictionary sources & meanings containing CGMP

CGMP